Health/Disease Strategy

There are several possible reasons that breastfeeding may influence breast cancer risk, according to the American Institute of Cancer Research. Find out what they are.

New research shows that these certain patients with breast cancer can benefit from genetic testing for all breast cancer genes.

Here’s what industry experts think after Cigna’s business model shift.

A new University of California, San Diego-led review has interesting findings about diabetes costs, patient care models and medication therapy.

Cigna publication project takes a page out of the big pharma and medical technology playbook.

Allegheny Health Network’s Susan Manzi, MD, MPH, discusses the healthcare needs of patients with lupus and other autoimmune disorders.

Today there are nearly 67,000 genetic tests. With so many tests available, it can be difficult for MCOs to determine what to cover.

A National Business Group on Health survey finds that with costs continuing to rise, employers are shifting control efforts to how healthcare is delivered and paid for.

A new report by the Blue Cross Blue Shield Association has eye-opening findings about diabetes prevalence, severity and cost.

New data presented at the International AIDS Society Conference examines the medical and financial burden of missing pills.

As the nation debates the future of our healthcare system, one idea gaining attention is a “Medicare-for-all” single-payer national health insurance plan.

An eye-opening study by Precision for Value assesses cancer value frameworks.

The medication’s ability to reduce inflammation sited as one possible explanation.

Study highlights the need for services and research for this understudied population.

An initiative that aims to expand the use of population health strategies has received funding to be used in 500 U.S. cities.

By using a patient-centered, physician-led model of care, Blue Cross Blue Shield (BCBS) of Michigan lowers recidivism and healthcare costs.

Here are five key strategies to improve care and outcomes for members with advanced illness.

Professor in the School for the Science of Health Care Delivery Natalia Wilson, MD, MPH, discusses teaching population health to the next-generation of physicians, and how it will transform care.

Views on the importance of population health differ depending on how you interact with patients, says the NEJM Care Redesign survey.

Understanding genetic variations and tumor differences in black women with breast cancer could lead to personalized diagnosis and treatment.

A real-world study of type 2 diabetes patients by Milliman has surprising findings on glycemic control and diabetes medication adherence.

A new study found that distinguishing between population health and community health strategies can help health organizations define clear goals and earmark the right resources to accomplish them.

A new study finds that expanding the way bundled payments are utilized could make a positive impact for patients and on costs.

A National Lipid Association survey has interesting findings on the prescription approval process for PCSK9 inhibitors.

Although drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.

Oak Street Health co-founder tells AHIP 2017 attendees about its novel approach to patient care.

Digital health pioneer Eric Topol talks about plans for a four-year precision medicine study at AHIP 2017.

AHIP 2017: Older adults with complex chronic conditions require payers to “look under the hood.”

It has been an exciting time at the Myeloma Institute at the University of Arkansas for Medical Sciences, on all fronts, namely, embarking on research that could play an important role in the development of preventative and curative strategies for multiple myeloma in the future.

Here are four things MCOs should know about a new study focusing on young patients with diabetes.